Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 870-874

  Wee, Christina C ^a   Phillips, Russell S ^a   Aurigemma, Gerard ^c   Erban, Stephen ^b   Kriegel, Gila ^a   Riley, Marilyn ^a   Douglas, Pamela S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b University of Massachusetts   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PHENTERMINE;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RISK; VALVULAR HEART DISEASE;

EID: 0032404014     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_1-199812010-00005     Document Type: Article

References (16)

1. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997. MMWR Morb Mortal Wkly Rep. 1997; 46:1061-6.
2. Connolly HM, Crary JU McGoon MD, Hensrud DS, Edwards BS, Edwards WD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-8.
3. Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87:1188-96.
4. Redfield MM, Nicholson WJ, Edwards WD, Tajik AJ. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations. Ann Intern Med. 1992;117:50-2.
5. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Taliercio CP, Taylor CL, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 1990;3:54-63.
6. Reid C, Gardin J, Yunis C, Kurosaki T, Flack J. Prevalence and clinical correlates of aortic and mitral regurgitation in a young adult population: The CARDIA Study [Abstract]. Circulation. 1994;90:1519.
7. Khan MA, Herzog CA, Peter JV, Hartley GG, Madlon-Kay R, Dick CD, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med. 1998;339:713-8.
8. Committee on Nutrition. Obesity Treatment Using Drug Therapy. White Paper Waltham MA: Massachusetts Medical Society; 1996.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
10. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651-4.
11. Otto CM, Pearlman AS. Textbook of Clinical Echocardiography. Philadelphia: WB Saunders; 1995:247-9.
12. Weyman AE. Principles and Practice of Echocardiography. 2d ed. Philadelphia: Lea & Febiger; 1994:431-9, 531-5.
13. Reid CL, Otto CM, Davis KB, Labovitz A, Kisslo KB, McKay CR. Influence of mitral valve morphology on mitral balloon commissurotomy: immediate and six-month results from the NHLBI Balloon Valvuloplasty Registry. Am Heart J. 1992;124:657-65.
14. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987;75:175-83.
15. Spain MG, Smith MD, Grayburn PA, Harlamert EA, DeMaria AN. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol. 1989;13: 585-90.
16. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol. 1987;9: 952-9.